128 related articles for article (PubMed ID: 14630980)
21. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
Lemaire R; Winne A; Sarkissian M; Lafyatis R
Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
[TBL] [Abstract][Full Text] [Related]
22. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors.
ten Dam GB; Zilch CF; Wallace D; Wieringa B; Beverley PC; Poels LG; Screaton GR
J Immunol; 2000 May; 164(10):5287-95. PubMed ID: 10799890
[TBL] [Abstract][Full Text] [Related]
23. Estradiol regulates the expression of CD45 splicing isoforms in lymphocytes.
Zhang T; Dong Z; Cai H; Rong J; Su Z
Mol Biol Rep; 2020 Apr; 47(4):3025-3030. PubMed ID: 32170460
[TBL] [Abstract][Full Text] [Related]
24. Hemophagocytic lymphohistiocytosis arising in a child with Langerhans cell histiocytosis.
Dokmanovic L; Krstovski N; Jankovic S; Janic D
Turk J Pediatr; 2014; 56(4):452-7. PubMed ID: 25818970
[TBL] [Abstract][Full Text] [Related]
25. Different types of in vivo induced cytolytic T lymphocytes are all LFA-Ihigh and lack CD45 exon 4 (CD45RA) but show distinct CD45RC profiles.
Hansson J; Ericsson PO; Widegren B; Dohlsten M; Sjögren HO; Hedlund G
Int Immunol; 1994 Sep; 6(9):1375-81. PubMed ID: 7819146
[TBL] [Abstract][Full Text] [Related]
26. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice.
Kishihara K; Penninger J; Wallace VA; Kündig TM; Kawai K; Wakeham A; Timms E; Pfeffer K; Ohashi PS; Thomas ML
Cell; 1993 Jul; 74(1):143-56. PubMed ID: 8334701
[TBL] [Abstract][Full Text] [Related]
27. A point mutation in the human CD45 gene associated with defective splicing of exon A.
Thude H; Hundrieser J; Wonigeit K; Schwinzer R
Eur J Immunol; 1995 Jul; 25(7):2101-6. PubMed ID: 7621884
[TBL] [Abstract][Full Text] [Related]
28. CD45 expression by murine B cells and T cells: alteration of CD45 isoforms in subpopulations of activated B cells.
Hathcock KS; Hirano H; Hodes RJ
Immunol Res; 1993; 12(1):21-36. PubMed ID: 8515182
[TBL] [Abstract][Full Text] [Related]
29. CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans.
Stanton T; Boxall S; Bennett A; Kaleebu P; Watera C; Whitworth J; French N; Dawes R; Hill AV; Bodmer W; Beverley PC; Tchilian EZ
Immunogenetics; 2004 May; 56(2):107-10. PubMed ID: 15057492
[TBL] [Abstract][Full Text] [Related]
30. Geographical distribution and disease associations of the CD45 exon 6 138G variant.
Ward V; Hennig BJ; Hirai K; Tahara H; Tamori A; Dawes R; Saito M; Bangham C; Stephens H; Goldfeld AE; Kunachiwa W; Leetrakool N; Hopkin J; Dunstan S; Hill A; Bodmer W; Beverley PC; Tchilian EZ
Immunogenetics; 2006 Apr; 58(2-3):235-9. PubMed ID: 16538473
[TBL] [Abstract][Full Text] [Related]
31. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors.
Rothstein DM; Saito H; Streuli M; Schlossman SF; Morimoto C
J Biol Chem; 1992 Apr; 267(10):7139-47. PubMed ID: 1532394
[TBL] [Abstract][Full Text] [Related]
32. A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.
Chellapandian D; Hines MR; Zhang R; Jeng M; van den Bos C; Santa-María López V; Lehmberg K; Sieni E; Wang Y; Nakano T; Williams JA; Fustino NJ; Astigarraga I; Dunkel IJ; Abla O; van Halteren AGS; Pei D; Cheng C; Weitzman S; Sung L; Nichols KE
Cancer; 2019 Mar; 125(6):963-971. PubMed ID: 30521100
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons.
Tong A; Nguyen J; Lynch KW
J Biol Chem; 2005 Nov; 280(46):38297-304. PubMed ID: 16172127
[TBL] [Abstract][Full Text] [Related]
34. Outcome of children treated with haematopoietic-stem cell transplantations from donors expressing the rare C77G variant of the PTPRC (CD45) gene.
Samaan S; Guérin-El Khourouj V; Auboeuf D; Peltier L; Pédron B; Ouachée-Chardin M; Gourgouillon N; Baruchel A; Dalle JH; Sterkers G
Br J Haematol; 2011 Apr; 153(1):47-57. PubMed ID: 21323873
[TBL] [Abstract][Full Text] [Related]
35. No association between systemic sclerosis and C77G polymorphism in the human PTPRC (CD45) gene.
Kirsten H; Blume M; Emmrich F; Hunzelmann N; Mierau R; Rzepka R; Vaith P; Witte T; Melchers I; Ahnert P
J Rheumatol; 2008 Sep; 35(9):1817-9. PubMed ID: 18634151
[TBL] [Abstract][Full Text] [Related]
36. Histiocytosis following T-acute lymphoblastic leukemia: a BFM study.
Trebo MM; Attarbaschi A; Mann G; Minkov M; Kornmüller R; Gadner H
Leuk Lymphoma; 2005 Dec; 46(12):1735-41. PubMed ID: 16263575
[TBL] [Abstract][Full Text] [Related]
37. A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues.
Li D; Brackenridge S; Screaton GR
Hum Immunol; 2004 Dec; 65(12):1539-45. PubMed ID: 15603882
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing.
Heyd F; Lynch KW
Mol Cell; 2010 Oct; 40(1):126-37. PubMed ID: 20932480
[TBL] [Abstract][Full Text] [Related]
39. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule.
Jacobsen M; Hoffmann S; Cepok S; Stei S; Ziegler A; Sommer N; Hemmer B
Immunogenetics; 2002 Jun; 54(3):158-63. PubMed ID: 12073144
[TBL] [Abstract][Full Text] [Related]
40. Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities.
Pulido R; Schlossman SF; Saito H; Streuli M
J Exp Med; 1994 Mar; 179(3):1035-40. PubMed ID: 7509359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
